• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)与颈围联合检测对冠心病患者的临床诊断意义

Clinical Diagnostic Significance of Combined Measurement of Lipoprotein(a) and Neck Circumference in Patients with Coronary Heart Disease.

作者信息

Yang Hui-Hui, Dou Jie, Guo Ruo-Ling, Gao Jie, Li Hui-Zhe, Wang Kun, Hou Tian-Hua, Wei Tie-Jun, Guo Jing-Tao, Liu Jian-Wei, Luo Dong-Lei

机构信息

Chengde Medical University, Chengde, People's Republic of China.

Department of Cardiology, Chengde Central Hospital/Second Clinical College of Chengde Medical University, Chengde, People's Republic of China.

出版信息

Int J Gen Med. 2024 Oct 30;17:5015-5027. doi: 10.2147/IJGM.S485570. eCollection 2024.

DOI:10.2147/IJGM.S485570
PMID:39494359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531722/
Abstract

OBJECTIVE

The study aimed to explore the clinical diagnostic significance of lipoprotein(a) [Lp(a)] and neck circumference (NC) in patients with coronary heart disease (CHD).

METHODS

This cross-sectional study was conducted at Chengde Central Hospital from September 2021 to June 2023, enrolling 791 patients with suspected CHD who underwent selective coronary angiography (CAG). Patients were categorized into CHD and non-CHD groups based on the severity of arterial narrowing. Subsequently, the diagnostic value of Lp(a) combined with NC in patients with CHD was assessed using receiver operating characteristic (ROC) curves. Based on the results of multivariate logistic regression, a nomogram was constructed, and its clinical applicability was validated using decision curve analysis (DCA) and clinical impact curve (CIC).

RESULTS

Multivariate logistic regression proved that high Lp(a) and high NC are risk factors for CHD, with OR of 1.836 (95% CI: 1.282-2.630) and 1.383 (1.0.978-1.955), respectively. Patients in the high NC or Lp(a) group exhibited a higher prevalence of multi-vessel disease. The area under the ROC curve (AUC) of the predictive model combining high Lp(a) and high NC was 0.710 (95% CI: 0.670-0.751) and also demonstrated good calibration (Hosmer-Lemeshow goodness-of-fit test value=0.494). The DCA and CIC confirmed the clinical utility of the nomogram developed to predict CHD based on the combination of high Lp(a) and high NC.

CONCLUSION

The levels of Lp(a) and NC exhibit a significant correlation with the presence of CHD, and their combined assessment holds specific clinical value in the diagnosis of CHD.

摘要

目的

本研究旨在探讨脂蛋白(a)[Lp(a)]和颈围(NC)在冠心病(CHD)患者中的临床诊断意义。

方法

本横断面研究于2021年9月至2023年6月在承德市中心医院进行,纳入791例接受选择性冠状动脉造影(CAG)的疑似CHD患者。根据动脉狭窄程度将患者分为CHD组和非CHD组。随后,使用受试者操作特征(ROC)曲线评估Lp(a)联合NC对CHD患者的诊断价值。基于多因素逻辑回归结果,构建列线图,并使用决策曲线分析(DCA)和临床影响曲线(CIC)验证其临床适用性。

结果

多因素逻辑回归证明,高Lp(a)和高NC是CHD的危险因素,OR分别为1.836(95%CI:1.282 - 2.630)和1.383(1.0978 - 1.955)。高NC或Lp(a)组患者多支血管病变的患病率更高。高Lp(a)和高NC联合预测模型的ROC曲线下面积(AUC)为0.710(95%CI:0.670 - 0.751),且校准良好(Hosmer-Lemeshow拟合优度检验值 = 0.494)。DCA和CIC证实了基于高Lp(a)和高NC联合开发的预测CHD列线图的临床实用性。

结论

Lp(a)和NC水平与CHD的存在显著相关,联合评估在CHD诊断中具有特定的临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/871da7116773/IJGM-17-5015-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/e94687c970bb/IJGM-17-5015-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/adf1af7652a5/IJGM-17-5015-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/e2ae9aa9fd7e/IJGM-17-5015-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/a0325f984cb2/IJGM-17-5015-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/871da7116773/IJGM-17-5015-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/e94687c970bb/IJGM-17-5015-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/adf1af7652a5/IJGM-17-5015-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/e2ae9aa9fd7e/IJGM-17-5015-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/a0325f984cb2/IJGM-17-5015-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2982/11531722/871da7116773/IJGM-17-5015-g0005.jpg

相似文献

1
Clinical Diagnostic Significance of Combined Measurement of Lipoprotein(a) and Neck Circumference in Patients with Coronary Heart Disease.脂蛋白(a)与颈围联合检测对冠心病患者的临床诊断意义
Int J Gen Med. 2024 Oct 30;17:5015-5027. doi: 10.2147/IJGM.S485570. eCollection 2024.
2
Development and validation of a clinical prediction model for detecting coronary heart disease in middle-aged and elderly people: a diagnostic study.开发和验证一种用于检测中老年人心血管疾病的临床预测模型:一项诊断研究。
Eur J Med Res. 2023 Sep 25;28(1):375. doi: 10.1186/s40001-023-01233-0.
3
[Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].[血清骨蛋白、炎性细胞因子水平与冠心病及其疾病严重程度的关系]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):588-593. doi: 10.3760/cma.j.issn.2095-4352.2019.05.013.
4
Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.冠心病患者血清缺血修饰白蛋白和脂蛋白相关磷脂酶A2水平及其与心肌缺血程度的相关性和诊断价值
Emerg Med Int. 2022 Jun 11;2022:1698315. doi: 10.1155/2022/1698315. eCollection 2022.
5
Clinical Value of the Diagonal Earlobe Crease in Patients with Chest Pain for Diagnosing Coronary Heart Disease.耳垂斜线纹在胸痛患者诊断冠心病中的临床价值
Int J Gen Med. 2024 Apr 23;17:1557-1569. doi: 10.2147/IJGM.S454888. eCollection 2024.
6
A risk predictive model for determining the severity of coronary artery lesions in older postmenopausal women with coronary heart disease.一种用于确定老年绝经后冠心病女性冠状动脉病变严重程度的风险预测模型。
Am J Cardiovasc Dis. 2024 Apr 15;14(2):106-115. doi: 10.62347/TWBY9801. eCollection 2024.
7
A web-based novel prediction model for predicting depression in elderly patients with coronary heart disease: A multicenter retrospective, propensity-score matched study.一种基于网络的预测老年冠心病患者抑郁的新型预测模型:一项多中心回顾性、倾向评分匹配研究。
Front Psychiatry. 2022 Oct 18;13:949753. doi: 10.3389/fpsyt.2022.949753. eCollection 2022.
8
The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.缺血修饰白蛋白(IMA)、红细胞分布宽度(RDW)及脂蛋白(LP)在糖尿病合并冠心病患者中的表达及预后价值
Ann Palliat Med. 2021 Apr;10(4):4463-4471. doi: 10.21037/apm-21-425. Epub 2021 Apr 16.
9
Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease.用于识别冠心病患者心力衰竭的非侵入性诊断列线图的建立与验证
Front Cardiovasc Med. 2022 Apr 7;9:875702. doi: 10.3389/fcvm.2022.875702. eCollection 2022.
10
Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes.2型糖尿病患者循环脂蛋白(a)水平与心血管事件风险之间的相关性。
Heliyon. 2024 Sep 4;10(17):e37415. doi: 10.1016/j.heliyon.2024.e37415. eCollection 2024 Sep 15.

本文引用的文献

1
Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary.《中国心血管健康与疾病报告 2022 概要》发布。
Biomed Environ Sci. 2023 Aug 20;36(8):669-701. doi: 10.3967/bes2023.106.
2
Machine learning approaches that use clinical, laboratory, and electrocardiogram data enhance the prediction of obstructive coronary artery disease.机器学习方法利用临床、实验室和心电图数据来提高对阻塞性冠状动脉疾病的预测能力。
Sci Rep. 2023 Aug 3;13(1):12635. doi: 10.1038/s41598-023-39911-y.
3
Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
脂蛋白(a)、氧化磷脂与冠状动脉疾病严重程度和结局。
J Am Coll Cardiol. 2023 May 9;81(18):1780-1792. doi: 10.1016/j.jacc.2023.02.050.
4
Lipoprotein (a), Inflammation, and Atherosclerosis.脂蛋白(a)、炎症与动脉粥样硬化
J Clin Med. 2023 Mar 27;12(7):2529. doi: 10.3390/jcm12072529.
5
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.脂蛋白(a)在临床实践中的应用:一个时机已至的生物标志物。美国国家脂质协会的科学声明。
J Clin Lipidol. 2022 Sep-Oct;16(5):e77-e95. doi: 10.1016/j.jacl.2022.08.007. Epub 2022 Aug 26.
6
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄:欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
7
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey.高脂蛋白(a)水平可预测因急性心肌梗死住院患者的冠状动脉疾病严重程度。来自法国 RICO 调查的数据。
J Clin Lipidol. 2022 Sep-Oct;16(5):685-693. doi: 10.1016/j.jacl.2022.07.006. Epub 2022 Jul 17.
8
[Chinese expert consensus on non-traditional blood lipid parameters to control the risks of arteriosclerotic cardiovascular disease].《中国非传统血脂参数防治动脉粥样硬化性心血管疾病风险专家共识》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Apr 6;56(4):405-421. doi: 10.3760/cma.j.cn112150-20211130-01106.
9
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.载脂蛋白(a)作为多种族亚洲人群冠心病和心肌梗死的预测因子。
Atherosclerosis. 2022 May;349:160-165. doi: 10.1016/j.atherosclerosis.2021.11.018. Epub 2021 Nov 26.
10
Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk.脂蛋白(a)与心血管疾病:早发动脉粥样硬化性心脏病和/或残余风险的缺失环节。
J Cardiovasc Pharmacol. 2022 Jan 1;79(1):e18-e35. doi: 10.1097/FJC.0000000000001160.